Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2023)

Historic Non Operating Income for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $787000.0.

  • Lexeo Therapeutics' Non Operating Income rose 2693.55% to $787000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $7.4 million for FY2024, which is 25077.87% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Non Operating Income of $787000.0 as of Q4 2023, which was up 2693.55% from $165000.0 recorded in Q3 2023.
  • Over the past 5 years, Lexeo Therapeutics' Non Operating Income peaked at $787000.0 during Q4 2023, and registered a low of $165000.0 during Q3 2023.